EP1.16-09 Delays in Care of Lung Cancer: A Moroccan Public Health Problem

For several years, lung cancer, which is responsible for one in five cancer deaths, has been considered the leading cause of cancer death. In Morocco, in 2018, 6488 new cases of lung cancer were reported for both sexes and all ages with 22,9% of all new cases of male cancer (Globocan) It”s a real public health problem The delay between the different therapeutic sequences has a real impact on survival, which makes it”s optimization a real public health issue. The aim of this work was to describe the care pathway for patients treated for lung cancer at the Mohamed VI Center, as well as the different treatment delays in our context. To do this, we conducted a monocentric, retrospective study in patients treated for lung cancer between January 2012 and November 2017 at the Mohamed VI Cancer treatment Center. To study this period and obtain significant results, we referred to the statistical rules and retained one month pey year, one year out of two, for a total of six months spread between January 2012 and November 2017 Using the oncology department’s database, we identified all patients with histologically confirmed lung cancer and a usable archived record that was summarized in a farm with pre-established responses coded as numerical variables. The key point of this study was the study of the time between the appearance of the first clinical signs and the initiation of the different therapeutic sequences discussed in a multidisciplinary meeting. During the study period, 125 cases of lung cancer were collected. The average age was 57,6 years The average consult time also called patient time was 3.92 months. As for the delays related to the health system there are: An average diagnostic time of 63,5 days A therapeutic delay of 67,9 days on average An average overall delay of 216,3 days The time to diagnosis was therefore close to that recommended by the littérature, while the consultation, treatment and overall time to diagnosis were longer which significantly affects the survival curve. In several countries, delays in care and access to care services, considered as indicators of system performance, have become a priority in public health policies. The establishment of more specialized oncology and radiation oncology centers should help to reduce them A subsequent reassessment of these delays, after correction, will male it possible to assess the evolution of the quality of the managementof this cancet at the Mohamed VI center.